Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor

European Journal of Pharmacology

Volumn 384, Issue 2-3, 1999, Pages 123-138

  Poon, Anthony ^a   Sawynok, Jana ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine deaminase; Adenosine kinase; Anti inflammatory; Antinociception

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 5' AMINO 5' DEOXYADENOSINE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; PENTOSTATIN; RECEPTOR SUBTYPE;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ADENOSINE DEAMINASE; ADENOSINE KINASE; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAFFEINE; CARRAGEENAN; CENTRAL NERVOUS SYSTEM STIMULANTS; DEOXYADENOSINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EDEMA; ENZYME INHIBITORS; HINDLIMB; HYPERALGESIA; INJECTIONS, SPINAL; MALE; NOCICEPTORS; PAIN; PENTOSTATIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SPINAL CORD; THEOBROMINE; TIME FACTORS;

EID: 0033458946     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00626-3     Document Type: Article

References (42)

1. Abbadie C., Besson J.-M. Effects of morphine and naloxone on basal and evoked Fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats. Pain. 52:1993;29-39.
2. Buritova J., Chapman V., Honoré P., Besson J.-M. Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal c-Fos expression in the rat. Brain Res. 715:1996;217-220.
3. Buritova J., Chapman V., Honoré P., Besson J.-M. Interactions between NMDA- and prostaglandin-receptor-mediated events in a model of inflammatory nociception. Eur. J. Pharmacol. 303:1996;91-100.
4. Carlton S.M., Zhou S. Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin. Pain. 76:1998;201-207.
5. Coderre T.J., Basbaum A.I., Levine J.D. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic afferents. J. Neurophysiol. 62:1989;48-58.
6. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
7. Cronstein B.N. Adenosine, neutrophil function, and inflammation. Jacobson K.A., Jarvis M.F. Purinergic Approaches in Experimental Therapeutics. 1997;285-299 Wiley-Liss, New York, NY.
8. Cronstein B.N., Kramer S.B., Weissmann G., Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158:1983;1160-1177.
9. Cronstein B.N., Levin R.I., Belanoff J., Weissmann G., Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest. 78:1986;760-770.
10. Cronstein B.N., Naime D., Ostad E. The anti-inflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:1993;2675-2682.
11. Davidson E.M., Carlton S.M. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. Brain Res. 785:1998;136-142.
12. Doak G.J., Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur. J. Pharmacol. 281:1995;311-318.
13. Draisci G., Iadorola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6:1989;31-37.
14. Gadangi P., Longaker M., Naime D., Levin R.I., Recht P.A., Montesinos M.C., Buckley M.T., Carlin G., Cronstein B.N. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J. Immunol. 156:1996;1937-1941.
15. Geiger J.D., Padua R.A., Nagy J.I. Adenosine deaminase regulation of purine actions. Phillis J.W. Adenosine and Adenine Nucleotides as Regulators of Cellular Function. 1991;71-84 CRC Press, Boca Raton, FL.
16. Golembiowska K., White T.D., Sawynok J. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res. 699:1995;315-320.
17. Golembiowska K., White T.D., Sawynok J. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur. J. Pharmacol. 307:1996;157-162.
18. Hargreaves K.M., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
19. Honoré P., Buritova J., Besson J.-M. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin. Eur. J. Pharmacol. 272:1995;249-259.
20. Honoré P., Buritova J., Besson J.-M. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation. Pain. 63:1995;365-375.
21. Honoré P., Chapman V., Buritova J., Besson J.-M. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression. Anesthesiology. 85:1996;150-160.
22. Hylden J.L.K, Thomas D.A., Iadarola M.J., Nahin R.L., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194:1991;135-143.
23. Jackson D.L., Graff C.B., Richardson J.D., Hargreaves K.M. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur. J. Pharmacol. 284:1995;321-325.
24. Jacobson K.A., van Rhee A.M. Development of selective purinoceptor agonists and antagonists. Jacobson K.A., Jarvis M.F. Purinergic Approaches in Experimental Therapeutics. 1997;101-128 Wiley-Liss, New York, NY.
25. Karlsten R., Gordh T., Post C. Local antinociception and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol. Toxicol. 70:1992;434-438.
26. Keil G.J., DeLander G.E. Spinally mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase inhibitor. Life Sci. 51:1992;171-176.
27. Keil G.J., DeLander G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur. J. Pharmacol. 271:1994;37-46.
28. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadorola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are co-localized in spinal cord neurons. Mol. Brain Res. 10:1991;227-233.
29. Poon A., Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur. J. Pharmacol. 286:1995;177-184.
30. Poon A., Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain. 74:1998;235-245.
31. Rosengren S., Arfors K.E., Proctor K.G. Potentiation of leukotriene B4-mediated inflammatory response by the adenosine antagonist, 8-phenyltheophylline. Int. J. Microcirc.: Clin. Exp. 10:1991;345-357.
32. Rosengren S., Bong G.W., Firestein G.S. Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage. J. Immunol. 154:1995;5444-5451.
33. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 317:1998;1-11.
34. 3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur. J. Pharmacol. 333:1997;1-7.
35. Sawynok J., Reid A., Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain. 74:1998;75-81.
36. Sawynok J., Reid A.R., Esser M.J. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain. 80:1999;45-55.
37. Taiwo Y.O., Levine J.D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 38:1990;757-762.
38. 2 receptors, adenosine inhibits production of tumor necrosis factor-α of endotoxin-stimulated polymorphonuclear leukocytes. J. Lab. Clin. Med. 126:1995;275-282.
39. 2 adenosine receptors. Life Sci. 39:1986;743-750.
40. Willis W.D., Coggeshall R.E. Structure of the dorsal horn. Willis W.D., Coggeshall R.E. Sensory Mechanisms of the Spinal Cord. 1991;79-151 Plenum, New York, NY.
41. Winter C.A., Risley H.A., Nuss G.W. Carrageenan-induced edema in hindpaw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
42. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.